• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

艰难梭菌毒素免疫检测阳性与聚合酶链反应检测结果阳性的血液系统恶性肿瘤患者的临床特征和结局。

Clinical Characteristics and Outcomes of Hematologic Malignancy Patients With Positive Clostridium difficile Toxin Immunoassay Versus Polymerase Chain Reaction Test Results.

机构信息

1Division of Infectious Diseases,Department of Healthcare Epidemiology,Infection Prevention and Control Perelman School of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania.

2Division of Hematology and Oncology,Department of Healthcare Epidemiology,Perelman School of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania.

出版信息

Infect Control Hosp Epidemiol. 2018 Jul;39(7):863-866. doi: 10.1017/ice.2018.83. Epub 2018 Apr 25.

DOI:10.1017/ice.2018.83
PMID:29690940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6031467/
Abstract

In a cohort of inpatients with hematologic malignancy and positive enzyme immunoassay (EIA) or polymerase chain reaction (PCR) Clostridium difficile tests, we found that clinical characteristics and outcomes were similar between these groups. The method of testing is unlikely to predict infection in this population, and PCR-positive results should be treated with concern.Infect Control Hosp Epidemiol 2018;863-866.

摘要

在一组患有血液恶性肿瘤且酶免疫测定 (EIA) 或聚合酶链反应 (PCR) 艰难梭菌检测阳性的住院患者中，我们发现这些组之间的临床特征和结局相似。检测方法不太可能预测该人群中的感染，并且应该对 PCR 阳性结果给予关注。感染控制与医院流行病学 2018;863-866.

相似文献

1
Clinical Characteristics and Outcomes of Hematologic Malignancy Patients With Positive Clostridium difficile Toxin Immunoassay Versus Polymerase Chain Reaction Test Results.艰难梭菌毒素免疫检测阳性与聚合酶链反应检测结果阳性的血液系统恶性肿瘤患者的临床特征和结局。
Infect Control Hosp Epidemiol. 2018 Jul;39(7):863-866. doi: 10.1017/ice.2018.83. Epub 2018 Apr 25.
2
Detection of antigen and toxin in stool specimens: Comparison of the quik chek complete enzyme immunoassay and GeneXpert polymerase chain reaction assay.粪便标本中抗原和毒素的检测：快速检测全酶免疫测定法与GeneXpert聚合酶链反应测定法的比较
Saudi J Gastroenterol. 2017 Jul-Aug;23(4):259-262. doi: 10.4103/sjg.SJG_80_17.
3
Evaluation of the diagnostic algorithm consisting of enzyme immunoassay for toxins and polymerase chain reaction, for the diagnosis of Clostridium difficile-associated diarrhoea.评估由毒素酶免疫测定和聚合酶链反应组成的诊断算法在艰难梭菌相关性腹泻诊断中的应用。
Scand J Infect Dis. 2012 Dec;44(12):969-72. doi: 10.3109/00365548.2012.695456. Epub 2012 Jul 19.
4
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.分子检测时代艰难梭菌感染的过度诊断
JAMA Intern Med. 2015 Nov;175(11):1792-801. doi: 10.1001/jamainternmed.2015.4114.
5
The evaluation of Clostridium difficile infection (CDI) in a community hospital.社区医院艰难梭菌感染（CDI）的评估。
J Infect Public Health. 2015 Mar-Apr;8(2):155-60. doi: 10.1016/j.jiph.2014.08.002. Epub 2014 Oct 6.
6
Searching for a Potential Algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing Help?在一家三级保健医院寻找艰难梭菌检测的潜在算法：毒素酶免疫测定检测是否有帮助？
J Clin Microbiol. 2018 Jun 25;56(7). doi: 10.1128/JCM.00415-18. Print 2018 Jul.
7
Molecular-based diagnosis of Clostridium difficile infection is associated with reduced mortality.基于分子的艰难梭菌感染诊断与降低死亡率相关。
Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1137-1142. doi: 10.1007/s10096-018-3228-4. Epub 2018 Apr 7.
8
Comparison of testing approaches for Clostridium difficile infection at a large community hospital.大型社区医院艰难梭菌感染检测方法的比较。
Clin Microbiol Infect. 2014 Jan;20(1):65-9. doi: 10.1111/1469-0691.12198. Epub 2013 Mar 23.
9
Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test.对比应用 PCR 技术诊断为谷氨酸脱氢酶阳性而毒素检测阴性的艰难梭菌感染患者与毒素检测阳性患者的临床病程。
Clin Microbiol Infect. 2018 Apr;24(4):414-421. doi: 10.1016/j.cmi.2017.07.033. Epub 2017 Aug 12.
10
Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital.实时聚合酶链反应检测艰难梭菌可缩短小型社区医院的隔离时间并改善患者管理。
Am J Infect Control. 2012 Sep;40(7):663-6. doi: 10.1016/j.ajic.2011.09.005. Epub 2011 Dec 6.

引用本文的文献

1
Management of infection in patients with haematological malignancies and after cellular therapy: guidelines from 10th European Conference on Infections in Leukaemia (ECIL-10).血液系统恶性肿瘤患者及细胞治疗后感染的管理：第十届欧洲白血病感染会议（ECIL-10）指南
EClinicalMedicine. 2025 Aug 7;87:103371. doi: 10.1016/j.eclinm.2025.103371. eCollection 2025 Sep.
2
Clinical significance of toxin EIA positivity in patients with suspected infection: systematic review and meta-analysis.疑似感染患者毒素酶免疫测定阳性的临床意义：系统评价与Meta分析
J Clin Microbiol. 2025 Jan 31;63(1):e0097724. doi: 10.1128/jcm.00977-24. Epub 2024 Dec 12.
3
An Update on Binary Toxin.二元毒素更新
Toxins (Basel). 2022 Apr 27;14(5):305. doi: 10.3390/toxins14050305.
4
Clinical Outcomes of Treated and Untreated C. difficile PCR-Positive/Toxin-Negative Adult Hospitalized Patients: a Quasi-Experimental Noninferiority Study.治疗和未治疗的 C. difficile PCR 阳性/毒素阴性成年住院患者的临床结局：一项准实验性非劣效性研究。
J Clin Microbiol. 2022 Jun 15;60(6):e0218721. doi: 10.1128/jcm.02187-21. Epub 2022 May 25.
5
Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results.诊断试验结果不一致的艰难梭菌感染患者的循环阈值、毒素浓度及临床特征评估
J Clin Microbiol. 2020 Apr 23;58(5). doi: 10.1128/JCM.01681-19.
6
Guideline implementation is effective at reducing proton pump inhibitor use in hematology-oncology units: A multidisciplinary intervention for reducing risk.指南的实施能有效减少血液肿瘤科质子泵抑制剂的使用：降低风险的多学科干预措施。
Infect Control Hosp Epidemiol. 2019 Nov;40(11):1294-1296. doi: 10.1017/ice.2019.238. Epub 2019 Aug 30.
7
Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.毒素酶免疫测定法检测艰难梭菌感染的严重程度更高，复发率更高。
Clin Infect Dis. 2019 Oct 30;69(10):1667-1674. doi: 10.1093/cid/ciz009.
8
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.口服万古霉素预防异基因造血细胞移植受者艰难梭菌感染的效果非常好。
Clin Infect Dis. 2019 May 30;68(12):2003-2009. doi: 10.1093/cid/ciy822.

本文引用的文献

1
Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test.对比应用 PCR 技术诊断为谷氨酸脱氢酶阳性而毒素检测阴性的艰难梭菌感染患者与毒素检测阳性患者的临床病程。
Clin Microbiol Infect. 2018 Apr;24(4):414-421. doi: 10.1016/j.cmi.2017.07.033. Epub 2017 Aug 12.
2
Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing.使用核酸检测对无症状和有症状住院患者进行艰难梭菌检测率的研究
Diagn Microbiol Infect Dis. 2017 Apr;87(4):365-370. doi: 10.1016/j.diagmicrobio.2016.12.014. Epub 2017 Jan 3.
3
Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation.造血干细胞移植后艰难梭菌毒素检测呈阳性的意义
Clin Transplant. 2016 Jun;30(6):703-8. doi: 10.1111/ctr.12737. Epub 2016 Apr 21.
4
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.分子检测时代艰难梭菌感染的过度诊断
JAMA Intern Med. 2015 Nov;175(11):1792-801. doi: 10.1001/jamainternmed.2015.4114.
5
Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains.造血干细胞移植受者艰难梭菌定植：一项关于产毒菌株和非产毒菌株的流行病学及结局的前瞻性研究。
Biol Blood Marrow Transplant. 2016 Jan;22(1):157-63. doi: 10.1016/j.bbmt.2015.07.020. Epub 2015 Jul 26.
6
Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation.造血干细胞移植患者艰难梭菌定植与疾病
Biol Blood Marrow Transplant. 2014 Sep;20(9):1329-34. doi: 10.1016/j.bbmt.2014.04.026. Epub 2014 May 2.
7
Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.根据艰难梭菌检测方法的结果差异：艰难梭菌感染的前瞻性多中心诊断验证研究。
Lancet Infect Dis. 2013 Nov;13(11):936-45. doi: 10.1016/S1473-3099(13)70200-7. Epub 2013 Sep 3.
8
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.艰难梭菌感染的诊断、治疗和预防指南。
Am J Gastroenterol. 2013 Apr;108(4):478-98; quiz 499. doi: 10.1038/ajg.2013.4. Epub 2013 Feb 26.
9
Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management.化疗相关性腹泻：病理生理学、频率及基于指南的管理。
Ther Adv Med Oncol. 2010 Jan;2(1):51-63. doi: 10.1177/1758834009355164.
10
Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.临床症状对艰难梭菌感染诊断检测结果解读的影响。
J Clin Microbiol. 2011 Aug;49(8):2887-93. doi: 10.1128/JCM.00891-11. Epub 2011 Jun 22.